top of page


Public·2 members

Buy Lactobacillus Gasseri

Lactobacillus gasseri is a species in the genus Lactobacillus identified in 1980 by François Gasser and his associates.[1] It is part of the vaginal flora.[2] Its genome has been sequenced.[3] L. gasseri is a normal inhabitant of the lower reproductive tract in healthy women.[4] It also produces Lactocillin.[5]

buy lactobacillus gasseri

Download Zip:

We describe the case of a 59-year-old man with a history of diabetes mellitus and multiple abdominal surgeries with the latest being in 2014 presenting with bacteremia and multiple large pyogenic liver abscesses due to Lactobacillus gasseri, which did not appear to be related to the use of probiotics or immunosuppression.

Given the high prevalence of diabetes mellitus and the increased use of probiotics, it is expected that in the future we will see an increase in infections caused by Lactobacilli. Medical management with antibiotics and percutaneous drainage were successful strategies for the treatment of this unusual case of pyogenic liver abscesses and bacteremia caused by Lactobacillus gasseri.

The incidence of bacteremia and liver abscesses due to Lactobacilli is rare, with only 10 cases reported in the literature [3, 9,10,11,12,13,14,15,16,17]. To our knowledge, this is the first case of a patient with a liver abscess and bacteremia caused by Lactobacillus gasseri.

Bacteremia and liver abscesses due to Lactobacillus are extremely rare. In a series from Finland, 89 cases of Lactobacillus bacteremia were identified. Of these, the species characterization of 47 were achieved; 25 being L. rhamnosus and 22 other species (L. fermentum 20%, L. casei 15%, L. gasseri, L. zeae). Immunosuppression, previous prolonged hospitalization, and previous surgical interventions were identified as independent risk factors [26]. Lactobacillus bacteremia implies a dark prognosis, with an associated mortality of 30% [25].

The fact the lactobacillus gasseri probiotic supplement is easy to take, is totally safe, benefits digestive health, and has weight regulation potential, makes it a must-buy daily supplement. If you are looking for high-quality, effective probiotics for weight loss, lactobacillus gasseri, or any of the other probiotic bacteria strains with protective effects we offer at Supersmart, are all great options.

Studies report consumption of a lactobacillus gasseri supplement may promote a reduction in abdominal adipose fat. A 12-week, double-blind Japanese study of 210 adults with abdominal adiposity showed that lactobacillus gasseri reduced BMI (Body Mass Index), waist and hip circumference, and abdominal fat mass by 8.5% in comparison with a control group where no such parameter changes were noted. However, researchers also found that regular ingestion is necessary for such effects to potentially endure.

According to this study, administration of lactobacillus gasseri suppressed increases in plasma leptin, suggesting that a reduction in weight and fat mass is associated with a decrease in serum leptin.

An increase in the activity of the GLUT4 gene: GLUT4 is one of the main transporters of glucose in skeletal muscle and adipose tissue. Increased expression of the GLUT4 gene in adipose tissue may improve resistance to the glucose-regulating peptide hormone. In this study, lactobacillus gasseri significantly increased expression of the GLUT4 gene in adipose tissue. In addition, the glucose-regulating peptide hormone levels fell significantly.

Since the increase in blood sugar levels in a condition characterized by an excess of the pancreatic hormone that regulates blood sugar levels stimulates the secretion of this hormone, which is frequently accompanied by obesity, consuming lactobacillus gasseri may help reduce resistance to the hormone that regulates glucose levels.

Each lactobacillus gasseri capsule is 100 mg and contains 6 billion microorganisms. For best results, we recommend adults take two lactobacillus gasseri capsules a day to meet the optimal daily serving of 200 mg, equivalent to 12 billion microorganisms. In order to preserve the lifespan of lactobacillus gasseri supplements, it is best to keep them refrigerated, especially if you live in a warm or humid climate.

In spite of the much evidence for the beneficial effects of probiotics, their anti-obesity effects have not been well examined. We evaluated the effects of the probiotic Lactobacillus gasseri SBT2055 (LG2055) on abdominal adiposity, body weight and other body measures in adults with obese tendencies.

Abstract:Short-term administration of Lactobacillus gasseri CP2305 improves stress-associated symptoms and clinical symptoms in healthy young adults and in patients with irritable bowel syndrome, respectively. We evaluated the efficacy and health benefits of the long-term use of a tablet containing heat-inactivated, washed Lactobacillus gasseri CP2305 (CP2305) in healthy young adults. Sixty Japanese medical students (41 men and 19 women) preparing for the national examination for medical practitioners ingested CP2305-containing or placebo tablets once daily for 24 weeks. Intake of the CP2305 tablet significantly reduced anxiety and sleep disturbance relative to placebo, as quantitated by the Spielberger State-Trait Anxiety Inventory and the Pittsburgh Sleep Quality Index. Single-channel sleep electroencephalograms show that CP2305 significantly shortened sleep latency and wake time after sleep onset and increased the delta power ratio in the first sleep cycle. CP2305 also significantly lowered salivary chromogranin A levels compared with placebo. Furthermore, 16S rRNA gene sequencing of participant feces demonstrated that CP2305 administration attenuated the stress-induced decline of Bifidobacterium spp. and the stress-induced elevation of Streptococcus spp. We conclude that the long-term use of CP2305-containing tablets may improve the mental state, sleep quality, and gut microbiota of healthy adults under stressful conditions.Keywords: heat-inactivated Lactobacillus gasseri CP2305; psychobiotics; healthy young adults; stress; mental health; sleep quality; fecal microbiota

Nishida, K.; Sawada, D.; Kuwano, Y.; Tanaka, H.; Rokutan, K. Health Benefits of Lactobacillus gasseri CP2305 Tablets in Young Adults Exposed to Chronic Stress: A Randomized, Double-Blind, Placebo-Controlled Study. Nutrients 2019, 11, 1859.

Nishida K, Sawada D, Kuwano Y, Tanaka H, Rokutan K. Health Benefits of Lactobacillus gasseri CP2305 Tablets in Young Adults Exposed to Chronic Stress: A Randomized, Double-Blind, Placebo-Controlled Study. Nutrients. 2019; 11(8):1859.

Nishida, Kensei, Daisuke Sawada, Yuki Kuwano, Hiroki Tanaka, and Kazuhito Rokutan. 2019. "Health Benefits of Lactobacillus gasseri CP2305 Tablets in Young Adults Exposed to Chronic Stress: A Randomized, Double-Blind, Placebo-Controlled Study" Nutrients 11, no. 8: 1859.

Lactobacilli are common commensal bacteria found in the gastrointestinal and genitourinary tract. Although they are usually thought to be nonpathogenic, there have been several cases that demonstrate severe infections caused by these microorganisms. This is a case of a 49-year-old male with previously undiagnosed type two diabetes mellitus who presented with a 3-month history of cough and was found to have right sided Lactobacillus gasseri empyema for which he underwent video-assisted thoracoscopic surgery (VATS) with chest tube placement. He subsequently developed a left sided pleural empyema for which the aspiration also grew out L. gasseri. The patient made a complete recovery and was seen for four months in follow-up after his initial presentation.

Lactobacillus gasseri is a member of the Lactobacillaceae family, a commensal organism of the gastrointestinal and genitourinary tract. It is rarely encountered as a cause of clinically significant infections. Previously reported cases include pneumonia, urinary tract infection, and polymicrobial empyema. In this case, we are presenting the first case of a monomicrobial Lactobacillus gasseri bilateral empyema that was successfully treated with source control and pathogen directed antibiotic therapy.

Lactobacillaceae are non-spore-forming, strictly anaerobic or facultative, Gram-positive bacilli that normally colonized in oral cavity, gastrointestinal tract, and female genital tract [1, 2]. Lactobacillus gasseri is a member of the Lactobacillaceae family which was first identified in 1980 and prior to that was named L. acidophilus [1, 2]. It thrives in anaerobic conditions and represents the major Lactobacillus species in the gut and plays a major role in maintaining a healthy bowel flora [1]. It is a non-spore-forming Gram-positive rod that is typically resistant to vancomycin and forms lactic acid from glucose [2]. In the food industry, it plays a role in fermentation of food products and is rarely pathogenic in humans [3]. Infectious cases reported in the literature cover a diverse span of clinical conditions including life-threatening conditions such as endocarditis [4], meningitis [5], splenic abscess [6], empyema and pneumonia [7], emphysematous pyelonephritis [8], peritonitis [9], and Fournier gangrene [2]. Many of the reported cases were associated with immunosuppressive conditions such as cancer, chemotherapy induced neutropenia, long term steroids, peritoneal dialysis, diabetes, transplantation, long term antibiotics, or postoperative complication. The most frequently associated infections with Lactobacillus are bacteremia and endocarditis, and L. casei and L. rhamnosus were most commonly encountered [10]. Infections by Lactobacillus gasseri are rarely reported in the literature. A case of Fournier gangrene [2], urinary tract infection [11], and polymicrobial empyema [7] were previously reported. In this case, we present the first monomicrobial Lactobacillus gasseri bilateral empyema that was successfully treated by video-assisted thoracoscopic surgery along with chest tube placement and drainage. Identification of the Lactobacillus species was made using matrix-assisted laser desorption ionization time-of-flight mass spectrometry which was done at a reference laboratory [12]. Pneumonia and subsequent empyema were the two most fatal diseases encountered in ancient time [13]. Hippocrates is credited with both naming and inventing the surgical technique for proper management [13]. Empyema remains a serious medical condition with associated morbidity and mortality. Common pathogens that are encountered include Streptococcus, Staphylococcus, Enterobacteriaceae, and anaerobes [14]. Despite the introduction of antibiotic therapy and the application of the scientific method to the modern practice of medicine when it comes to managing empyema, the core principle is still adequate drainage. 041b061a72


Welcome to the group! You can connect with other members, ge...
bottom of page